デング熱ワクチンの世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Dengue Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-15746 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、デング熱ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。デング熱ワクチンの種類別市場規模（Dengvaxia、TAK-003、その他）、用途別市場規模（公共、個人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Takeda ・地域別グローバル市場分析 2015年-2020年 ・デング熱ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・デング熱ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・デング熱ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・デング熱ワクチンの南米市場（ブラジル、アルゼンチン） ・デング熱ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Dengvaxia、TAK-003、その他 ・用途別分析：公共、個人 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Dengue Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Dengue Vaccines market has been segmented into:
Dengvaxia
TAK-003
Others

By Application, Dengue Vaccines has been segmented into:
Public Sector
Private Sector

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dengue Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Dengue Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dengue Vaccines market.

The report offers in-depth assessment of the growth and other aspects of the Dengue Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Dengue Vaccines Market Share Analysis
Dengue Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dengue Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dengue Vaccines sales, revenue and market share for each player covered in this report.

The major players covered in Dengue Vaccines are:
Sanofi
Takeda

レポート目次

---

Table of Contents

1 Dengue Vaccines Market Overview
1.1 Product Overview and Scope of Dengue Vaccines
1.2 Classification of Dengue Vaccines by Type
1.2.1 Global Dengue Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Dengue Vaccines Revenue Market Share by Type in 2019
1.2.3 Dengvaxia
1.2.4 TAK-003
1.2.5 Others
1.3 Global Dengue Vaccines Market by Application
1.3.1 Overview: Global Dengue Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Global Dengue Vaccines Market by Regions
1.4.1 Global Dengue Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Dengue Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Dengue Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Dengue Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dengue Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Dengue Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dengue Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Dengue Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Dengue Vaccines Players Market Share
3.2.2 Top 10 Dengue Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Dengue Vaccines Revenue and Market Share by Regions
4.2 North America Dengue Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Dengue Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Dengue Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Dengue Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Dengue Vaccines Revenue and Growth Rate (2015-2020)
5 North America Dengue Vaccines Revenue by Countries
5.1 North America Dengue Vaccines Revenue by Countries (2015-2020)
5.2 USA Dengue Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Dengue Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Dengue Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Dengue Vaccines Revenue by Countries
6.1 Europe Dengue Vaccines Revenue by Countries (2015-2020)
6.2 Germany Dengue Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Dengue Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Dengue Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Dengue Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Dengue Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Dengue Vaccines Revenue by Countries
7.1 Asia-Pacific Dengue Vaccines Revenue by Countries (2015-2020)
7.2 China Dengue Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Dengue Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Dengue Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Dengue Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Dengue Vaccines Revenue and Growth Rate (2015-2020)
8 South America Dengue Vaccines Revenue by Countries
8.1 South America Dengue Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Dengue Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Dengue Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Dengue Vaccines by Countries
9.1 Middle East & Africa Dengue Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Dengue Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Dengue Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Dengue Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Dengue Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Dengue Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Dengue Vaccines Market Forecast by Type (2019-2024)
10.3 Dengvaxia Revenue Growth Rate (2015-2025)
10.4 TAK-003 Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Dengue Vaccines Market Segment by Application
11.1 Global Dengue Vaccines Revenue Market Share by Application (2015-2020)
11.2 Dengue Vaccines Market Forecast by Application (2019-2024)
11.3 Public Sector Revenue Growth (2015-2020)
11.4 Private Sector Revenue Growth (2015-2020)
12 Global Dengue Vaccines Market Size Forecast (2021-2025)
12.1 Global Dengue Vaccines Market Size Forecast (2021-2025)
12.2 Global Dengue Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Dengue Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Dengue Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Dengue Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Dengue Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Dengue Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Dengue Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dengue Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Dengue Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sanofi Corporate Information, Location and Competitors
Table 6. Sanofi Dengue Vaccines Major Business
Table 7. Sanofi Dengue Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Sanofi SWOT Analysis
Table 9. Sanofi Dengue Vaccines Product and Solutions
Table 10. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Takeda Corporate Information, Location and Competitors
Table 12. Takeda Dengue Vaccines Major Business
Table 13. Takeda Dengue Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Takeda SWOT Analysis
Table 15. Takeda Dengue Vaccines Product and Solutions
Table 16. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Global Dengue Vaccines Revenue (Million USD) by Players (2015-2020)
Table 18. Global Dengue Vaccines Revenue Share by Players (2015-2020)
Table 19. Global Dengue Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 20. Global Dengue Vaccines Revenue Market Share by Regions (2015-2020)
Table 21. North America Dengue Vaccines Revenue by Countries (2015-2020)
Table 22. North America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 23. Europe Dengue Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 24. Asia-Pacific Dengue Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 25. South America Dengue Vaccines Revenue by Countries (2015-2020)
Table 26. South America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 27. Middle East and Africa Dengue Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 28. Middle East and Africa Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 29. Global Dengue Vaccines Revenue (Million USD) by Type (2015-2020)
Table 30. Global Dengue Vaccines Revenue Share by Type (2015-2020)
Table 31. Global Dengue Vaccines Revenue Forecast by Type (2021-2025)
Table 32. Global Dengue Vaccines Revenue by Application (2015-2020)
Table 33. Global Dengue Vaccines Revenue Share by Application (2015-2020)
Table 34. Global Dengue Vaccines Revenue Forecast by Application (2021-2025)
Table 35. Global Dengue Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Dengue Vaccines Picture
Figure 2. Global Dengue Vaccines Revenue Market Share by Type in 2019
Figure 3. Dengvaxia Picture
Figure 4. TAK-003 Picture
Figure 5. Others Picture
Figure 6. Dengue Vaccines Revenue Market Share by Application in 2019
Figure 7. Public Sector Picture
Figure 8. Private Sector Picture
Figure 9. Global Dengue Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Dengue Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Dengue Vaccines Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Dengue Vaccines Revenue Market Share in 2019
Figure 18. Global Top 10 Players Dengue Vaccines Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Dengue Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Dengue Vaccines Revenue Market Share by Regions (2015-2020)
Figure 22. Global Dengue Vaccines Revenue Market Share by Regions in 2018
Figure 23. North America Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 24. Europe Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. South America Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. North America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 29. North America Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 30. USA Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Canada Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Europe Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 35. Germany Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. UK Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. France Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. Russia Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Italy Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 42. China Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Japan Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Korea Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. India Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. South America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 48. South America Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 49. Brazil Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. UAE Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Dengue Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. Global Dengue Vaccines Revenue Share by Type (2015-2020)
Figure 58. Global Dengue Vaccines Revenue Share by Type in 2019
Figure 59. Global Dengue Vaccines Market Share Forecast by Type (2021-2025)
Figure 60. Global Dengvaxia Revenue Growth Rate (2015-2020)
Figure 61. Global TAK-003 Revenue Growth Rate (2015-2020)
Figure 62. Global Others Revenue Growth Rate (2015-2020)
Figure 63. Global Dengue Vaccines Revenue Share by Application (2015-2020)
Figure 64. Global Dengue Vaccines Revenue Share by Application in 2019
Figure 65. Global Dengue Vaccines Market Share Forecast by Application (2021-2025)
Figure 66. Global Public Sector Revenue Growth Rate (2015-2020)
Figure 67. Global Private Sector Revenue Growth Rate (2015-2020)
Figure 68. Global Dengue Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Dengue Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Dengue Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Dengue Vaccines Revenue Market Forecast (2021-2025)
Figure 72. Europe Dengue Vaccines Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Dengue Vaccines Revenue Market Forecast (2021-2025)
Figure 74. South America Dengue Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Dengue Vaccines Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---